Heart Test Laboratories, Inc. (HSCS) Stock Statistics & Valuation Metrics

Heart Test Laboratories, Inc. has a market cap or net worth of $11.90M. The enterprise value is $11.97M.

Market Cap

$11.90M

Enterprise Value

$11.97M

Heart Test Laboratories, Inc. has 4,969,283 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

4,969,283

Owned by Insiders

10.15%

Owned by Institutions

2.85%

Heart Test Laboratories, Inc.’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -0.20%.

Return on Equity (ROE)

-0.04

Return on Assets (ROA)

-0.00

Return on Invested Capital (ROIC)

-0.20%

Return on Capital Employed (ROCE)

-0.02

Revenue Per Employee

308.5

Profits Per Employee

-652.99K

Employee Count

14

Asset Turnover

0.00

Inventory Turnover

0.00

The current PE Ratio of Heart Test Laboratories, Inc. is -0.72. Heart Test Laboratories, Inc.’s PEG ratio is -0.01.

PE Ratio

-0.72

PS Ratio

2523.68

PB Ratio

-4.14

Price to FCF

-1.67

Price to Operating Cash Flow

-1.24

PEG Ratio

-0.01

In the last 12 months, Heart Test Laboratories, Inc. had revenue of 4,319 and earned -9.14M in profits. Earnings per share was -3.48.

Revenue

4,319

Gross Profit

-128.80K

Operating Income

-8.41M

Pretax Income

-9.14M

Net Income

-9.14M

EBITDA

-8.28M

Earnings Per Share (EPS)

-3.48

In the last 12 months, operating cash flow was -6.79M and capital expenditures -43,638, giving a free cash flow of -6.84M billion.

Operating Cash Flow

-6.79M

Free Cash Flow

-6.84M

Free Cash Flow per Share

-1.86

Heart Test Laboratories, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-60.07%

Earnings Yield

-122.11%

Beta

0.52

52-Week Price Change

-22.47%

50-Day Moving Average

3.62

200-Day Moving Average

2.69

Relative Strength Index (RSI)

35.90

Average Volume (3m)

135.07K

Heart Test Laboratories, Inc. upcoming earnings date is Dec 21, 2026, TBA (Not Confirmed).

Last Earnings Date

Sep 15, 2026

Next Earnings Date

Dec 21, 2026

Ex-Dividend Date

―

Heart Test Laboratories, Inc. as a current ratio of 0.53, with Debt / Equity ratio of 1745.53%

Current Ratio

0.53

Quick Ratio

0.40

Debt to Market Cap

707.50

Net Debt to EBITDA

-275.29

Interest Coverage Ratio

-11.17

In the past 12 months, Heart Test Laboratories, Inc. has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Heart Test Laboratories, Inc. EV to EBITDA ratio is 1.55, with an EV/FCF ratio of 2.12.

EV to Sales

-3213.50

EV to EBITDA

1.55

EV to Free Cash Flow

2.12

EV to Operating Cash Flow

2.14

Heart Test Laboratories, Inc. has $29.91M in cash and marketable securities with $4.00M in debt, giving a net cash position of $25.90M billion.

Cash & Marketable Securities

$29.91M

Total Debt

$4.00M

Net Cash

$25.90M

Net Cash Per Share

$5.21

Tangible Book Value Per Share

-$453.76

Gross margin is -2908.83%, with operating margin of -209733.08%, and net profit margin of -227024.23%.

Gross Margin

-2908.83%

Operating Margin

-209733.08%

Pretax Margin

-227024.23%

Net Profit Margin

-227024.23%

EBITDA Margin

-206763.38%

EBIT Margin

-209733.08%

The average price target for Heart Test Laboratories, Inc. is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$12.00

Price Target Upside

422.88% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

-27.70%

EPS Growth Forecast

61.44%

Smart Score

―

AI Score

46